Latest From Biotech Now

International Rare Disease Day: Join the Movement

Nicole Boice

By Nicole Boice, President and Founder, RARE Project Being diagnosed with any illness can be overwhelming. Imagine what it’s like, though, to be diagnosed with a disease that you’ve never heard of – maybe even one that your doctor has never seen before. Millions of people start this diagnostic odyssey on their own, with little or no support, no real direction, with feelings of isolation and fear. That’s exactly the situation in which millions of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Industry Outlook in Anticipation of the 2012 BIO International Convention

HC5O7460

This month, BIO wrapped the 14th Annual CEO & Investor Conference in New York City at the Waldorf=Astoria. Hosted by BIO, the event drew more than 1,200 industry leaders, featured 140 company presentations and a record breaking 1,300+ one-on-one meetings between 225 companies. Taking the momentum from this meeting, we now look ahead to the 2012 BIO International Convention to be held June 18 – 21, 2012 at the Boston Convention & Exhibition Center in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Shoppers Already Have a Choice Regarding Biotech Foods

Greg Conko

Food Chemical News (an Agra Informa publication) ran a thorough editorial in its February 17 edition on the biotech food labeling debate. In this piece, Gregory Conko, a senior fellow at the Competitive Enterprise Institute, explains why it would be unnecessary to require special labeling for foods containing biotech ingredients: “Today, there are many thousands of affirmatively labeled, non-biotech foods available in stores as varied as Whole Foods Markets and Wal-Mart. “From just 2000 to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Oncology Clinical Trials – Secrets of Success

Graph

At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that drugs in development for oncology indications had the lowest overall clinical trial success rate of all therapeutic areas in development since 2004. We have updated these numbers to include clinical trials through December 2011. Although overall success rates did improve slightly, oncology remained in last place. The chart below illustrates why oncology’s overall success rate is so low relative to Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Presidential Memo Expands Purchases of Biobased Products and Creates Jobs

biobased-btn

This week President Obama issued a Presidential Memorandum that challenges the federal government to substantially increase purchases of biobased products over the next two years, driving new job growth and innovation. The United States Department of Agriculture (USDA) already designates 64 categories of biobased products for federal procurement and this memorandum asks Agriculture Secretary Tom Vilsack to increase the number of both designated categories of and individual biobased products eligible for preferred purchasing by 50 Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , ,